Education Library

Resources for Health Care Professionals

Filter Results





May 6, 2022

Heparin-Free Purge: Bicarbonate-Based Purge Solution

A bicarbonate-based purge solution for Impella® may be a viable alternative to heparin-based purge solution in patients who are heparin-intolerant and when heparin is contraindicated.

April 5, 2022

Case Study: PCCS Care Pathway and Use of Impella 5.5® with SmartAssist® Heart Pump

A heart team approach and hemodynamic assessment led to timely and effective use of Impella 5.5 with SmartAssist for this patient with PCCS.

March 16, 2022

Acute on Chronic Heart Failure and Cardiogenic Shock

Claudius Mahr, DO, discusses outcome differences between patients with acute de novo cardiogenic shock and patients with chronic heart failure deteriorating to shock.

March 14, 2022

Right Heart Catheterization in Cardiogenic Shock Associated with Improved Outcomes

Zubair Shah, MD, explains how his research revealed improved outcomes in patients with cardiogenic shock receiving right heart catheterization.

February 22, 2022

IABP for Acute-On-Chronic Heart Failure Complicated by Cardiogenic Shock

Federico Pappalardo, MD, describes the role of IABP in the treatment of acute-on-chronic heart failure complicated by cardiogenic shock. 

February 3, 2022

Impella® Transport Considerations

Adam Gottula, MD, discusses considerations for optimizing patient care when transporting patients supported with Impella or other mechanical circulatory support devices.

February 2, 2022

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

December 7, 2021

Clinical Analysis of Impella® in High-Risk PCI

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

November 5, 2021

TCT 2021: SCAI Shock Stage Update

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

November 3, 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

November 3, 2021

HFSA 2021: Identifying Patients for PROTECT IV

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

November 3, 2021

HFSA 2021: Management Considerations for HFCS

Jaime Hernandez-Montfort, MD, discusses management considerations for heart failure cardiogenic shock (HFCS) at HFSA 2021.

November 2, 2021

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

November 1, 2021

HFSA 2021: Cardiogenic Shock Patients Can Achieve Heart Recovery

Shelley Hall, MD, discusses what can be done about cardiogenic shock and where the field is going, and issues a call for achieving heart recovery.

October 29, 2021

Data-Driven Point-of-Care Risk Model in Patients with AMICS

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI.